Found: 2740
Select item for more details and to access through your institution.
Keep your eye on...
- Published in:
- Brown University Child & Adolescent Behavior Letter, 2024, v. 40, n. 10, p. 2, doi. 10.1002/cbl.30817
- By:
- Publication type:
- Article
Response to Comment on Garvey et al. Association of Baseline Factors With Glycemic Outcomes in GRADE: A Comparative Effectiveness Randomized Clinical Trial. Diabetes Care 2024;47:562–570.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Comment on Garvey et al. Association of Baseline Factors With Glycemic Outcomes in GRADE: A Comparative Effectiveness Randomized Clinical Trial. Diabetes Care 2024;47:562–570.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Use of a Dual GIP/GLP-1 Receptor Agonist in HNF1A-MODY and HNF4A-MODY.
- Published in:
- 2024
- By:
- Publication type:
- Letter
The effectiveness of 0.5 mg and 1mg of semaglutide in patients with type two diabetes and predictors of response: a retrospective cohort study.
- Published in:
- Frontiers in Endocrinology, 2024, p. 1, doi. 10.3389/fendo.2024.1395651
- By:
- Publication type:
- Article
GLP-1 Agonists for Obesity.
- Published in:
- 2024
- By:
- Publication type:
- Letter
EHR Data Suggest Tirzepatide Outdoes Semaglutide for Weight Loss.
- Published in:
- JAMA: Journal of the American Medical Association, 2024, v. 332, n. 8, p. 610, doi. 10.1001/jama.2024.13770
- By:
- Publication type:
- Article
Weight Loss Drugs Linked With Lower Risk of 10 Cancers.
- Published in:
- JAMA: Journal of the American Medical Association, 2024, v. 332, n. 8, p. 611, doi. 10.1001/jama.2024.13774
- By:
- Publication type:
- Article
Understanding the Molecular Dynamics of Type-2 Diabetes Drug Target DPP-4 and its Interaction with Sitagliptin and Inhibitor Diprotin-A.
- Published in:
- Cell Biochemistry & Biophysics, 2014, v. 70, n. 2, p. 907, doi. 10.1007/s12013-014-9998-0
- By:
- Publication type:
- Article
Impact of difructose anhydride III, raffinose, and fructooligosaccharides on energy intake, gut hormones, and cecal fermentation in rats fed a high-fat and high-sucrose diet.
- Published in:
- Bioscience, Biotechnology & Biochemistry, 2017, v. 81, n. 11, p. 2186, doi. 10.1080/09168451.2017.1373591
- By:
- Publication type:
- Article
Multifunctional Antibody Agonists Targeting Glucagon-like Peptide-1, Glucagon, and Glucose-Dependent Insulinotropic Polypeptide Receptors.
- Published in:
- Angewandte Chemie, 2016, v. 128, n. 40, p. 12663, doi. 10.1002/ange.201606321
- By:
- Publication type:
- Article
Glucagon-Like Peptide 1 Protects against Hyperglycemic-Induced Endothelial-to-Mesenchymal Transition and Improves Myocardial Dysfunction by Suppressing Poly(ADP-Ribose) Polymerase 1 Activity.
- Published in:
- Molecular Medicine, 2015, v. 21, n. 1, p. 15, doi. 10.2119/molmed.2014.00259
- By:
- Publication type:
- Article
GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes.
- Published in:
- Acta Diabetologica, 2024, v. 61, n. 8, p. 941, doi. 10.1007/s00592-024-02300-6
- By:
- Publication type:
- Article
Blood pressure-lowering effects of SGLT2 inhibitors and GLP-1 receptor agonists for preventing of cardiovascular events and death in type 2 diabetes: a systematic review and meta-analysis.
- Published in:
- Acta Diabetologica, 2023, v. 60, n. 12, p. 1651, doi. 10.1007/s00592-023-02154-4
- By:
- Publication type:
- Article
Pregnancy glucagon-like peptide 1 predicts insulin but not glucose concentrations.
- Published in:
- Acta Diabetologica, 2023, v. 60, n. 12, p. 1635, doi. 10.1007/s00592-023-02142-8
- By:
- Publication type:
- Article
GLP-1RAs and cardiovascular disease: is the endothelium a relevant platform?
- Published in:
- Acta Diabetologica, 2023, v. 60, n. 11, p. 1441, doi. 10.1007/s00592-023-02124-w
- By:
- Publication type:
- Article
The effects of dipeptidyl peptidase-4 inhibitors and glucagon-like peptide 1 receptor agonists on cognitive functions in adults with type 2 diabetes mellitus: a systematic review and meta-analysis.
- Published in:
- Acta Diabetologica, 2020, v. 57, n. 10, p. 1129, doi. 10.1007/s00592-020-01529-1
- By:
- Publication type:
- Article
Advances in micro- and nanotechnologies for the GLP-1-based therapy and imaging of pancreatic beta-cells.
- Published in:
- Acta Diabetologica, 2018, v. 55, n. 5, p. 405, doi. 10.1007/s00592-017-1086-7
- By:
- Publication type:
- Article
GLP-1 receptor agonists in type 1 diabetes: a proof-of-concept approach.
- Published in:
- Acta Diabetologica, 2015, v. 52, n. 6, p. 1129, doi. 10.1007/s00592-015-0800-6
- By:
- Publication type:
- Article
Short-term effects of glucagon-like peptide 1 (GLP-1) receptor agonists on fat distribution in patients with type 2 diabetes mellitus: an ultrasonography study.
- Published in:
- Acta Diabetologica, 2015, v. 52, n. 4, p. 727, doi. 10.1007/s00592-014-0710-z
- By:
- Publication type:
- Article
GLP-1 receptor agonist-induced polyarthritis: a case report.
- Published in:
- 2014
- By:
- Publication type:
- Report
Pancreatitis associated with the use of GLP-1 analogs and DPP-4 inhibitors: a case/non-case study from the French Pharmacovigilance Database.
- Published in:
- Acta Diabetologica, 2014, v. 51, n. 3, p. 491, doi. 10.1007/s00592-013-0544-0
- By:
- Publication type:
- Article
Different modulation of dipeptidyl peptidase-4 activity between microvascular and macrovascular human endothelial cells.
- Published in:
- Acta Diabetologica, 2012, v. 49, p. 59, doi. 10.1007/s00592-010-0195-3
- By:
- Publication type:
- Article
Miglitol administered before breakfast increased plasma active glucagon-like peptide-1 (GLP-1) levels after lunch in patients with type 2 diabetes treated with sitagliptin.
- Published in:
- Acta Diabetologica, 2012, v. 49, n. 3, p. 225, doi. 10.1007/s00592-011-0322-9
- By:
- Publication type:
- Article
Erratum to: Miglitol administered before breakfast increased plasma active glucagon-like peptide-1 (GLP-1) levels after lunch in patients with type 2 diabetes treated with sitagliptin.
- Published in:
- 2012
- By:
- Publication type:
- Correction notice
GLP-1 ANALOGUES AND OBESITY -- FROM MEDICAL USE TO DIVERSION AND DRUG ABUSE.
- Published in:
- Acta Marisiensis. Seria Medica, 2024, v. 70, p. 110
- By:
- Publication type:
- Article
Evaluation of Insulin and Glucagon-Like Peptide-1 Analog Sales in Turkey Before the Pandemic Period; Projection for Upcoming Years: A Market Analysis Study.
- Published in:
- Sakarya Tıp Dergisi, 2023, v. 13, n. 1, p. 48, doi. 10.31832/smj.1021311
- By:
- Publication type:
- Article
CIRURGIA METABÓLICA COMO TRATAMENTO CIRÚRGICO DO DIABETES TIPO II.
- Published in:
- Revista Foco (Interdisciplinary Studies Journal), 2023, v. 16, n. 9, p. 1, doi. 10.54751/revistafoco.v16n9-098
- By:
- Publication type:
- Article
Development of the Diabetes Injection Device Experience Questionnaire (DID-EQ) and Diabetes Injection Device Preference Questionnaire (DID-PQ).
- Published in:
- Journal of Patient-Reported Outcomes, 2018, v. 2, n. 1, p. N.PAG, doi. 10.1186/s41687-018-0068-z
- By:
- Publication type:
- Article
Psychometric evaluation of the Diabetes Injection Device Experience Questionnaire (DID-EQ) and Diabetes Injection Device Preference Questionnaire (DID-PQ).
- Published in:
- Journal of Patient-Reported Outcomes, 2018, v. 2, n. 1, p. N.PAG, doi. 10.1186/s41687-018-0064-3
- By:
- Publication type:
- Article
The endocrine pancreas in non-diabetic rats after short-term and long-term treatment with the long-acting GLP-1 derivative NN2211.
- Published in:
- APMIS, 2003, v. 111, n. 12, p. 1117, doi. 10.1111/j.1600-0463.2003.apm1111207.x
- By:
- Publication type:
- Article
Weekly Semaglutide vs. Liraglutide Efficacy Profile: A Network Meta-Analysis.
- Published in:
- Healthcare (2227-9032), 2021, v. 9, n. 9, p. 1125, doi. 10.3390/healthcare9091125
- By:
- Publication type:
- Article
COST-UTILITY ANALYSIS OF LIRAGLUTIDE VERSUS GLIMEPIRIDE AS ADD-ON TO METFORMIN IN TYPE 2 DIABETES PATIENTS IN CHINA.
- Published in:
- International Journal of Technology Assessment in Health Care, 2012, v. 28, n. 4, p. 436, doi. 10.1017/S0266462312000608
- By:
- Publication type:
- Article
Glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes.
- Published in:
- Annals of Pediatric Endocrinology & Metabolism, 2017, v. 22, n. 1, p. 15, doi. 10.6065/apem.2017.22.1.15
- By:
- Publication type:
- Article
Cardiology News / Recent Literature Review / Third Quarter 2020.
- Published in:
- Rhythmos, 2020, v. 15, n. 4, p. 80
- By:
- Publication type:
- Article
GLP-1 Receptor Stimulation Reduces Amyloid-β Peptide Accumulation and Cytotoxicity in Cellular and Animal Models of Alzheimer's Disease.
- Published in:
- Journal of Alzheimer's Disease, 2010, v. 19, n. 4, p. 1205, doi. 10.3233/JAD-2010-1314
- By:
- Publication type:
- Article
Anti-atherosclerotic effects of the glucagon-like peptide-1 (GLP-1) based therapies in patients with type 2 Diabetes Mellitus: A meta-analysis.
- Published in:
- Scientific Reports, 2015, p. 10202, doi. 10.1038/srep10202
- By:
- Publication type:
- Article
Characterization of Two Parabacteroides distasonis Candidate Strains as New Live Biotherapeutics against Obesity.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 9, p. 1260, doi. 10.3390/cells12091260
- By:
- Publication type:
- Article
Venom Peptides, Polyphenols and Alkaloids: Are They the Next Antidiabetics That Will Preserve β-Cell Mass and Function in Type 2 Diabetes?
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 6, p. 940, doi. 10.3390/cells12060940
- By:
- Publication type:
- Article
Duodenal Dual-Wavelength Photobiomodulation Improves Hyperglycemia and Hepatic Parameters with Alteration of Gut Microbiome in Type 2 Diabetes Animal Model.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 21, p. 3490, doi. 10.3390/cells11213490
- By:
- Publication type:
- Article
GLP-1 Receptor Agonists in Neurodegeneration: Neurovascular Unit in the Spotlight.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 13, p. N.PAG, doi. 10.3390/cells11132023
- By:
- Publication type:
- Article
The Role of GLP1 in Rat Steatotic and Non-Steatotic Liver Transplantation from Cardiocirculatory Death Donors.
- Published in:
- Cells (2073-4409), 2019, v. 8, n. 12, p. 1599, doi. 10.3390/cells8121599
- By:
- Publication type:
- Article
Liraglutide Inhibits Endothelial-to-Mesenchymal Transition and Attenuates Neointima Formation after Endovascular Injury in Streptozotocin-Induced Diabetic Mice.
- Published in:
- Cells (2073-4409), 2019, v. 8, n. 6, p. 589, doi. 10.3390/cells8060589
- By:
- Publication type:
- Article
Efficacy and safety of sodium–glucose co‐transporter‐2 inhibitors in kidney transplant recipients with diabetes mellitus.
- Published in:
- Diabetic Medicine, 2024, v. 41, n. 8, p. 1, doi. 10.1111/dme.15383
- By:
- Publication type:
- Article
Dorothy Hodgkin lecture 2023: The enteroendocrine system—Sensors in your guts.
- Published in:
- Diabetic Medicine, 2023, v. 40, n. 12, p. 1, doi. 10.1111/dme.15212
- By:
- Publication type:
- Article
Impact of novel glucose‐lowering therapies on physical function in people with type 2 diabetes: A systematic review and meta‐analysis of randomised placebo‐controlled trials.
- Published in:
- Diabetic Medicine, 2023, v. 40, n. 6, p. 1, doi. 10.1111/dme.15083
- By:
- Publication type:
- Article
INnoVative trial design for testing the Efficacy, Safety and Tolerability of 6‐month treatment with incretin‐based therapy to prevent type 1 DIAbetes in autoantibody positive participants: A protocol for three parallel double‐blind, randomised controlled trials (INVESTDIA)
- Published in:
- Diabetic Medicine, 2022, v. 39, n. 10, p. 1, doi. 10.1111/dme.14913
- By:
- Publication type:
- Article
Prescribing costs of hypoglycaemic agents and associations with metabolic control in Wales; a national analysis of primary care data.
- Published in:
- Diabetic Medicine, 2022, v. 39, n. 9, p. 1, doi. 10.1111/dme.14908
- By:
- Publication type:
- Article
Persistent disparities in diabetes medication receipt by socio‐economic disadvantage in Australia.
- Published in:
- Diabetic Medicine, 2022, v. 39, n. 9, p. 1, doi. 10.1111/dme.14898
- By:
- Publication type:
- Article
New frontiers in the hunger management involving GLP‐1, taste and oestrogen.
- Published in:
- 2022
- Publication type:
- Letter to the Editor